• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于CT图像评估的脂肪和肌肉相关指标的模型,用于预测肝癌患者的微血管侵犯。

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients.

作者信息

Mao Xin-Cheng, Shi Shuo, Yan Lun-Jie, Wang Han-Chao, Ding Zi-Niu, Liu Hui, Pan Guo-Qiang, Zhang Xiao, Han Cheng-Long, Tian Bao-Wen, Wang Dong-Xu, Tan Si-Yu, Dong Zhao-Ru, Yan Yu-Chuan, Li Tao

机构信息

Department of General Surgery, Qilu Hospital, Shandong University, 107 West Wen Hua Road, Jinan, 250012, China.

Department of Radiology, Qilu Hospital, Shandong University, Jinan, China.

出版信息

Biomark Res. 2023 Oct 4;11(1):87. doi: 10.1186/s40364-023-00527-z.

DOI:10.1186/s40364-023-00527-z
PMID:37794517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10548702/
Abstract

BACKGROUND AND AIM

The presence of microvascular invasion (MVI) will impair the surgical outcome of hepatocellular carcinoma (HCC). Adipose and muscle tissues have been confirmed to be associated with the prognosis of HCC. We aimed to develop and validate a nomogram based on adipose and muscle related-variables for preoperative prediction of MVI in HCC.

METHODS

One hundred fifty-eight HCC patients from institution A (training cohort) and 53 HCC patients from institution B (validation cohort) were included, all of whom underwent preoperative CT scan and curative resection with confirmed pathological diagnoses. Least absolute shrinkage and selection operator (LASSO) logistic regression was applied to data dimensionality reduction and screening. Nomogram was constructed based on the independent variables, and evaluated by external validation, calibration curve, receiver operating characteristic (ROC) curve and decision curve analysis (DCA).

RESULTS

Histopathologically identified MVI was found in 101 of 211 patients (47.9%). The preoperative imaging and clinical variables associated with MVI were visceral adipose tissue (VAT) density, intramuscular adipose tissue index (IMATI), skeletal muscle (SM) area, age, tumor size and cirrhosis. Incorporating these 6 factors, the nomogram achieved good concordance index of 0.79 (95%CI: 0.72-0.86) and 0.75 (95%CI: 0.62-0.89) in training and validation cohorts, respectively. In addition, calibration curve exhibited good consistency between predicted and actual MVI probabilities. ROC curve and DCA of the nomogram showed superior performance than that of models only depended on clinical or imaging variables. Based on the nomogram score, patients were divided into high (> 273.8) and low (< = 273.8) risk of MVI presence groups. For patients with high MVI risk, wide-margin resection or anatomical resection could significantly improve the 2-year recurrence free survival.

CONCLUSION

By combining 6 preoperative independently predictive factors of MVI, a nomogram was constructed. This model provides an optimal preoperative estimation of MVI risk in HCC patients, and may help to stratify high-risk individuals and optimize clinical decision making.

摘要

背景与目的

微血管侵犯(MVI)的存在会损害肝细胞癌(HCC)的手术效果。脂肪组织和肌肉组织已被证实与HCC的预后相关。我们旨在开发并验证一种基于脂肪和肌肉相关变量的列线图,用于术前预测HCC中的MVI。

方法

纳入来自机构A的158例HCC患者(训练队列)和来自机构B的53例HCC患者(验证队列),所有患者均接受了术前CT扫描及根治性切除,并经病理确诊。应用最小绝对收缩和选择算子(LASSO)逻辑回归进行数据降维和筛选。基于自变量构建列线图,并通过外部验证、校准曲线、受试者工作特征(ROC)曲线和决策曲线分析(DCA)进行评估。

结果

211例患者中有101例(47.9%)经组织病理学鉴定存在MVI。与MVI相关的术前影像和临床变量包括内脏脂肪组织(VAT)密度、肌内脂肪组织指数(IMATI)、骨骼肌(SM)面积、年龄、肿瘤大小和肝硬化。纳入这6个因素后,列线图在训练队列和验证队列中的一致性指数分别为0.79(95%CI:0.72 - 0.86)和0.75(95%CI:0.62 - 0.89)。此外,校准曲线显示预测的MVI概率与实际概率之间具有良好的一致性。列线图的ROC曲线和DCA显示其性能优于仅依赖临床或影像变量的模型。根据列线图评分,将患者分为MVI存在风险高(> 273.8)和低(<= 273.8)两组。对于MVI风险高的患者,宽切缘切除或解剖性切除可显著提高2年无复发生存率。

结论

通过结合6个术前MVI的独立预测因素,构建了列线图。该模型为HCC患者的MVI风险提供了最佳的术前估计,可能有助于对高危个体进行分层并优化临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/71f9a4fd0068/40364_2023_527_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/95d97c3fd623/40364_2023_527_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/a3821865a1db/40364_2023_527_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/2f37a6e1b8d0/40364_2023_527_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/ed9044f5fc49/40364_2023_527_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/d68cd6ddbd28/40364_2023_527_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/0baeeb10a9a0/40364_2023_527_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/71f9a4fd0068/40364_2023_527_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/95d97c3fd623/40364_2023_527_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/a3821865a1db/40364_2023_527_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/2f37a6e1b8d0/40364_2023_527_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/ed9044f5fc49/40364_2023_527_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/d68cd6ddbd28/40364_2023_527_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/0baeeb10a9a0/40364_2023_527_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bce6/10548702/71f9a4fd0068/40364_2023_527_Fig7_HTML.jpg

相似文献

1
A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients.一种基于CT图像评估的脂肪和肌肉相关指标的模型,用于预测肝癌患者的微血管侵犯。
Biomark Res. 2023 Oct 4;11(1):87. doi: 10.1186/s40364-023-00527-z.
2
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.一种结合血液学和影像学特征的列线图在肝细胞癌患者微血管侵犯术前预测中的开发与验证
Ann Transl Med. 2021 Mar;9(5):402. doi: 10.21037/atm-20-4695.
3
Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma.基于临床数据库的肝癌微血管侵犯预测术前列线图。
Sci Rep. 2021 Jul 7;11(1):13999. doi: 10.1038/s41598-021-93528-7.
4
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.米兰标准范围内乙型肝炎病毒相关性肝细胞癌微血管侵犯风险的术前预测列线图。
JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.
5
Novel Nomogram Based on Inflammatory Markers for the Preoperative Prediction of Microvascular Invasion in Solitary Primary Hepatocellular Carcinoma.基于炎症标志物的新型列线图用于术前预测孤立性原发性肝细胞癌微血管侵犯
Cancer Manag Res. 2022 Mar 1;14:895-907. doi: 10.2147/CMAR.S346976. eCollection 2022.
6
Assessment of an MR Elastography-Based Nomogram as a Potential Imaging Biomarker for Predicting Microvascular Invasion of Hepatocellular Carcinoma.基于磁共振弹性成像的列线图评估作为预测肝细胞癌微血管侵犯的潜在影像学生物标志物。
J Magn Reson Imaging. 2023 Aug;58(2):392-402. doi: 10.1002/jmri.28553. Epub 2022 Dec 8.
7
A novel nomogram for predicting microvascular invasion in hepatocellular carcinoma.一种用于预测肝细胞癌微血管侵犯的新型列线图。
Ann Hepatol. 2023 Nov-Dec;28(6):101136. doi: 10.1016/j.aohep.2023.101136. Epub 2023 Jul 20.
8
Preoperative prediction of microvascular invasion in non-metastatic hepatocellular carcinoma based on nomogram analysis.基于列线图分析的非转移性肝细胞癌微血管侵犯的术前预测
Transl Oncol. 2021 Jan;14(1):100875. doi: 10.1016/j.tranon.2020.100875. Epub 2020 Sep 23.
9
Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion.列线图辅助肝细胞癌手术规划:微血管侵犯预测模型。
J Gastrointest Surg. 2019 Dec;23(12):2372-2382. doi: 10.1007/s11605-019-04140-0. Epub 2019 Feb 28.
10
A multidimensional nomogram combining imaging features and clinical factors to predict the invasiveness and metastasis of combined hepatocellular cholangiocarcinoma.一种结合影像特征和临床因素以预测肝内胆管癌侵袭和转移的多维度列线图。
Ann Transl Med. 2021 Oct;9(20):1518. doi: 10.21037/atm-21-2500.

引用本文的文献

1
A serum TNFR2-based model effectively predicates preoperative microvascular invasion and stratifies the tumor recurrence risk in hepatocellular carcinoma.一种基于血清肿瘤坏死因子受体2(TNFR2)的模型可有效预测术前微血管侵犯,并对肝细胞癌的肿瘤复发风险进行分层。
BMC Gastroenterol. 2025 Aug 27;25(1):622. doi: 10.1186/s12876-025-04152-y.
2
Preoperative prediction model of microvascular invasion in intrahepatic cholangiocarcinoma patients based on CT radiomics can assist clinical surgical decision-making: a multicenter study.基于CT影像组学的肝内胆管癌患者微血管侵犯术前预测模型可辅助临床手术决策:一项多中心研究
Eur Radiol. 2025 Aug 14. doi: 10.1007/s00330-025-11900-x.
3

本文引用的文献

1
Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study.构建并验证基于 SEER 数据库的多中心肝细胞癌患者列线图模型。
Eur J Surg Oncol. 2023 Oct;49(10):106966. doi: 10.1016/j.ejso.2023.06.018. Epub 2023 Jun 21.
2
What Is the Role of Body Composition Assessment in HCC Management?身体成分评估在肝癌管理中的作用是什么?
Cancers (Basel). 2022 Oct 27;14(21):5290. doi: 10.3390/cancers14215290.
3
The value of CT radiomic in differentiating mycoplasma pneumoniae pneumonia from streptococcus pneumoniae pneumonia with similar consolidation in children under 5 years.
Imbalance between skeletal muscle and intermuscular fat predicts treatment failure in Crohn's disease: an imaging biomarker for risk stratification.
骨骼肌与肌间脂肪失衡预示克罗恩病治疗失败:一种用于风险分层的影像学生物标志物
Ann Med. 2025 Dec;57(1):2536756. doi: 10.1080/07853890.2025.2536756. Epub 2025 Jul 25.
4
Using F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer.利用F-FDG PET/CT得出的身体成分特征预测非小细胞肺癌中的淋巴管侵犯
Eur J Nucl Med Mol Imaging. 2025 Jul 23. doi: 10.1007/s00259-025-07435-4.
5
Computed tomography radiomics combined with clinical parameters for hepatocellular carcinoma differentiation: a machine learning investigation.计算机断层扫描影像组学联合临床参数用于肝细胞癌分化:一项机器学习研究
Pol J Radiol. 2025 Mar 24;90:e140-e150. doi: 10.5114/pjr/200631. eCollection 2025.
6
Increment of Skeletal Muscle Mass Predicts Survival Benefit for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors.骨骼肌质量增加可预测经动脉化疗栓塞联合分子靶向药物和免疫检查点抑制剂治疗的肝细胞癌患者的生存获益。
J Hepatocell Carcinoma. 2025 Feb 27;12:415-426. doi: 10.2147/JHC.S506412. eCollection 2025.
7
Enhanced prediction of 5-year postoperative recurrence in hepatocellular carcinoma by incorporating LASSO regression and random forest models.通过结合套索回归和随机森林模型增强肝细胞癌术后5年复发的预测
Surg Endosc. 2025 Apr;39(4):2540-2550. doi: 10.1007/s00464-025-11631-6. Epub 2025 Mar 3.
8
Clonorchis sinensis infection contributes to hepatocellular carcinoma progression via enhancing angiogenesis.华支睾吸虫感染通过促进血管生成促进肝细胞癌的进展。
PLoS Negl Trop Dis. 2024 Nov 11;18(11):e0012638. doi: 10.1371/journal.pntd.0012638. eCollection 2024 Nov.
9
Clinical Nomogram Model for Pre-Operative Prediction of Microvascular Invasion of Hepatocellular Carcinoma before Hepatectomy.临床列线图模型预测肝癌切除术前行微血管侵犯的术前预测。
Medicina (Kaunas). 2024 Aug 28;60(9):1410. doi: 10.3390/medicina60091410.
10
A nomogram incorporating Psoas muscle index for predicting tumor recurrence after liver transplantation: A retrospective study in an Eastern Asian population.纳入腰大肌指数预测肝移植术后肿瘤复发的列线图:东亚人群的回顾性研究
Heliyon. 2024 Jul 3;10(16):e34019. doi: 10.1016/j.heliyon.2024.e34019. eCollection 2024 Aug 30.
CT影像组学在鉴别5岁以下儿童支原体肺炎与表现相似实变的肺炎链球菌肺炎中的价值
Front Pediatr. 2022 Sep 28;10:953399. doi: 10.3389/fped.2022.953399. eCollection 2022.
4
Impact of sarcopenia on outcomes of patients undergoing liver resection for hepatocellular carcinoma.肌肉减少症对肝细胞癌患者行肝切除术治疗结局的影响。
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2383-2392. doi: 10.1002/jcsm.13040. Epub 2022 Jul 19.
5
Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis.较高的皮下脂肪组织放射密度与肝硬化患者死亡率增加相关。
JHEP Rep. 2022 Apr 27;4(7):100495. doi: 10.1016/j.jhepr.2022.100495. eCollection 2022 Jul.
6
Preoperative Assessment of Abdominal Adipose Tissue to Predict Microvascular Invasion in Small Hepatocellular Carcinoma.腹部脂肪组织的术前评估以预测小肝细胞癌的微血管侵犯
J Clin Transl Hepatol. 2022 Apr 28;10(2):184-189. doi: 10.14218/JCTH.2021.00126. Epub 2021 Jul 7.
7
The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort.肌肉减少症和肌脂肪变性在欧洲队列中肝细胞癌根治性手术后短期和长期预后中的作用
Cancers (Basel). 2022 Jan 30;14(3):720. doi: 10.3390/cancers14030720.
8
Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma.锌指蛋白的结构、生物学功能及其在肝细胞癌中的作用
Biomark Res. 2022 Jan 9;10(1):2. doi: 10.1186/s40364-021-00345-1.
9
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management.肝细胞癌中的肌肉减少症:发病机制与管理。
Chemotherapy. 2022;67(3):152-163. doi: 10.1159/000521741. Epub 2021 Dec 31.
10
Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma.液体活检用于鉴定肝细胞癌免疫治疗的生物标志物。
Biomark Res. 2021 Dec 20;9(1):91. doi: 10.1186/s40364-021-00348-y.